Marshall Wace’s Moderna MRNA Stock Holding History

Marshall Wace’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.6M	Buy	70,900 +67,000	+1,718%	+$3.13M	﹤0.01%	1473
2025 Q4	$115K	Buy	3,900 +3,700	+1,850%	+$101K	﹤0.01%	2698
2025 Q3	$5.17K	Buy	+200	New	+$5.58K	﹤0.01%	2826
2023 Q3	–	Sell	-3,600	Closed	-$437K	–	2504
2023 Q2	$437K	Sell	3,600 -31,300	-90%	-$4.18M	﹤0.01%	2027
2023 Q1	$5.36M	Sell	34,900 -61,300	-64%	-$10.1M	0.01%	967
2022 Q4	$17.3M	Buy	96,200 +29,000	+43%	+$4.74M	0.04%	514
2022 Q3	$7.96M	Sell	67,200 -18,600	-22%	-$2.82M	0.02%	1053
2022 Q2	$12.3M	Sell	85,800 -96,600	-53%	-$13.8M	0.03%	729
2022 Q1	$31.4M	Buy	+182,400	New	+$30.7M	0.06%	352

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's MRNA Position: Q1 2026 in Review

Marshall Wace increased its Moderna (MRNA) stake by 12% in Q1 2026, buying an estimated $671K and bringing the position to 133,815 shares worth $6.8M. The position accounts for 0.01% of the portfolio, ranked #1153.

Marshall Wace first reported a position in MRNA in Q2 2019 and has held it in 20 quarters since. The position peaked at $139M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Marshall Wace held 133,815 shares of Moderna worth $6.8M as of Q1 2026.
Marshall Wace bought 14,374 Moderna shares in Q1 2026, an estimated $671K.
Moderna made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1153 holding.
Marshall Wace first reported a position in Moderna in Q2 2019 and has held it in 20 quarters since.
Marshall Wace's Moderna position peaked at $139M in Q1 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.